Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Blood|October 22, 2008
Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003Madhav V Dhodapkar, Antje Hoering, Morie A Gertz, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 11, 2023
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung CancerHisao Asamura, Katherine K Nishimura, Dorothy J Giroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Reiterative survival analyses of total therapy 2 for multiple myeloma elucidate follow-up time dependency of prognostic variables and treatment armsBart Barlogie, Elias Anaissie, Frits van Rhee, et al.
The American Journal of Surgical Pathology|December 6, 2005
Adult B-cell lymphomas with burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behaviorRebecca F McClure, Ellen D Remstein, William R Macon, et al.
Leukemia & Lymphoma|October 1, 2015
Risk of multiple myeloma in a case-spouse studyGabriella Andreotti, Michael Katz, Antje Hoering, et al.
Cancer|October 15, 2010
International staging system and metaphase cytogenetic abnormalities in the era of gene expression profiling data in multiple myeloma treated with total therapy 2 and 3 protocolsSarah Waheed, John D Shaughnessy, Frits van Rhee, et al.
Blood|February 4, 2010
Superior results of Total Therapy 3 (2003-33) in gene expression profiling-defined low-risk multiple myeloma confirmed in subsequent trial 2006-66 with VRD maintenanceBijay Nair, Frits van Rhee, John D Shaughnessy, et al.
Blood|June 12, 2009
Complete remission in multiple myeloma examined as time-dependent variable in terms of both onset and duration in Total Therapy protocolsAntje Hoering, John Crowley, John D Shaughnessy, et al.
Sarcoma|November 27, 2018
SARC018_SPORE02: Phase II Study of Mocetinostat Administered with Gemcitabine for Patients with Metastatic Leiomyosarcoma with Progression or Relapse following Prior Treatment with Gemcitabine-Containing TherapyEdwin Choy, Karla Ballman, James Chen, et al.
Blood|January 12, 2013
Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3Saad Z Usmani, Alan Mitchell, Sarah Waheed, et al.
Pageof 8